APA (7th ed.) Citation

T, A., Y, T., T, M., K, A., N, I., E, S., . . . T, T. (2022). Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3). Modern rheumatology, 32(2), 273. https://doi.org/10.1093/mr/roab021

Chicago Style (17th ed.) Citation

T, Atsumi, et al. "Efficacy and Safety of Filgotinib Alone and in Combination with Methotrexate in Japanese Patients with Active Rheumatoid Arthritis and Limited or No Prior Exposure to Methotrexate: Subpopulation Analyses of 24-week Data of a Global Phase 3 Study (FINCH 3)." Modern Rheumatology 32, no. 2 (2022): 273. https://doi.org/10.1093/mr/roab021.

MLA (9th ed.) Citation

T, Atsumi, et al. "Efficacy and Safety of Filgotinib Alone and in Combination with Methotrexate in Japanese Patients with Active Rheumatoid Arthritis and Limited or No Prior Exposure to Methotrexate: Subpopulation Analyses of 24-week Data of a Global Phase 3 Study (FINCH 3)." Modern Rheumatology, vol. 32, no. 2, 2022, p. 273, https://doi.org/10.1093/mr/roab021.